Bozcuk, H. Ş. Et Al. 2004. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. CYTOKINE , vol.27, no.2-3 , 58-65.

Bozcuk, H. Ş., Uslu, G., Samur, M., Yıldız, M., Ozben, T., Özdoğan, M., ... Artaç, M.(2004). Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. CYTOKINE , vol.27, no.2-3, 58-65.

Bozcuk, HAKAN Et Al. "Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy," CYTOKINE , vol.27, no.2-3, 58-65, 2004

Bozcuk, HAKAN Ş. Et Al. "Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy." CYTOKINE , vol.27, no.2-3, pp.58-65, 2004

Bozcuk, H. Ş. Et Al. (2004) . "Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy." CYTOKINE , vol.27, no.2-3, pp.58-65.

@article{article, author={HAKAN ŞAT BOZCUK Et Al. }, title={Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy}, journal={CYTOKINE}, year=2004, pages={58-65} }